Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

66.37 -0.39 (-0.58%)
Official Closing Price Updated: 7:00 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corp

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Amid More Evidence of Tough Competition, Teladoc Stock Remains a Sell
Teladoc's slowing growth and increased spending indicates that its competition is increasingly tough, making TDOC stock a sell. 
Via InvestorPlace
Teledoc Stock Will Break Out with New Product Features
Teledoc’s product suite myStrength Complete and Primary 360 will enhance growth in the coming quarters and into 2023. With Teledoc's integration with Livongo's product features, the company is bound to... 
Via InvestorPlace
Exposures COVID-19
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Director Of Centene Sold $1.4M In Stock
Richard Gephardt, Director at Centene (NYSE:CNC), made a large insider sell on October 28, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Analyst Ratings For Centene
Analysts have provided the following ratings for Centene (NYSE:CNC) within th... 
Via Benzinga
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
Via Benzinga
Analyst Ratings For Centene
Over the past 3 months, 10 analysts have published their opinion on Centene (NYSE:... 
Via Benzinga
Centene Raises Sales Outlook, Narrows Earnings Guidance For FY21
Centene Corporation (NYSE: CNC) has reported Q3 adjusted EPS of $1.26, slightly beating the consensus estimate of $1.25. Sales increased 11% Y/Y to $32.4 billion,... 
Via Benzinga
Centene Corporation (CNC) Q3 2021 Earnings Call Transcript
CNC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Centene Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q3, Centene (NYSE:CNC) earned $969.00 million, a 355.67% increase from the preceding quarter. Centene also posted a total of $32.41 billion in... 
Via Benzinga
Recap: Centene Q3 Earnings
Centene (NYSE:CNC) reported its Q3 earnings results on Tuesday, October 26, 2021 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Thoughts For Thursday: Markets Higher And Halloween Closer
Via Talk Markets
Why Centene Shares Are Rising
Shares of healthcare providers and insurers, including Centene Corp (NYSE: CNC) are trading higher in sympathy with Anthem, which gained after reporting better-than-expected... 
Via Benzinga
Analyst Ratings For Centene
Centene (NYSE:CNC) has observed the following analyst ratings within the last... 
Via Benzinga
Analyst Ratings For Centene
Analysts have provided the following ratings for Centene (NYSE:C... 
Via Benzinga
Where Centene Stands With Analysts
Within the last quarter, Centene (NYSE:CNC) has observed the following analys... 
Via Benzinga
A Bearish Sign Appears On Centene's Chart
If history is any guide, there may be trouble ahead for shares of Centene(NYSE:CNC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
Cramer Weighs In On Joby Aviation, Pitney Bowes And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Celularity Inc (NASDAQ: CELU) is interesting. Nobody likes it, but if you buy it here, you might get really... 
Via Benzinga
What 9 Analyst Ratings Have To Say About Centene
Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:... 
Via Benzinga
CNC: This Leading Healthcare Stock Is Getting Attractive
The next major support level for Centene Corp's stock will be around the $59.00 area. This support level is where the stock was defended in late April 2021 before surging to its July 2021 top. 
Via Talk Markets
Understanding Centene's Unusual Options Activity
Shares of Centene (NYSE:CNC) saw some unusual options activi... 
Via Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
Earnings Scheduled For July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
Via Benzinga
What 10 Analyst Ratings Have To Say About Centene
Within the last quarter, Centene (NYSE:CNC) has observed the... 
Via Benzinga
Centene Corporation (CNC) Q2 2021 Earnings Call Transcript
CNC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Centene Reports Mixed Bag On Q2 Earnings, Raises FY2021 Sales Outlook
Centene Corporation (NYSE: CNC) reported Q2 adjusted EPS of $1.25, missing the consensus estimate of $1.39 and lower than $2.40 reported a year ago. Sales for the... 
Via Benzinga
Centene: Q2 Earnings Insights
Shares of Centene (NYSE:CNC) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share decreased 47.92% over the past year to $1.25, which... 
Via Benzinga
Biogen's Costly Alzheimer's Treatment May Face Restricted Medicare Access: WSJ
The recent approval of Biogen Inc's (NASDAQ: BIIB) high-price Alzheimer's drug is raising questions about who will have access to the $56,000/year... 
Via Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.